Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;28(2):322-30.
doi: 10.1007/s11095-010-0249-9. Epub 2010 Nov 6.

Chemical inhibitors of the calcium entry channel TRPV6

Christopher P Landowski  1 , Katrin A Bolanz, Yoshiro Suzuki, Matthias A Hediger
Affiliations
Free article

Chemical inhibitors of the calcium entry channel TRPV6

Christopher P Landowski et al. Pharm Res. 2011 Feb.
Free article

Abstract

Purpose: Calcium entry channels in the plasma membrane are thought to play a major role in maintaining cellular Ca(2+) levels, crucial for growth and survival of normal and cancer cells. The calcium-selective channel TRPV6 is expressed in prostate, breast, and other cancer cells. Its expression coincides with cancer progression, suggesting that it drives cancer cell growth. However, no specific inhibitors for TRPV6 have been identified thus far.

Methods: To develop specific TRPV6 inhibitors, we synthesized molecules based on the lead compound TH-1177, reported to inhibit calcium entry channels in prostate cancer cells in vitro and in vivo.

Results: We found that one of our compounds (#03) selectively inhibited TRPV6 over five times better than TRPV5, whereas TH-1177 and the other synthesized compounds preferentially inhibited TRPV5. The IC(50) value for growth inhibition by blocking endogenous Ca(2+) entry channels in the LNCaP human prostate cancer cell line was 0.44 ± 0.07 μM compared to TH-1177 (50 ± 0.4 μM).

Conclusions: These results suggest that compound #03 is a relatively selective and potent inhibitor for TRPV6 and that it is an interesting lead compound for the treatment of prostate cancer and other cancers of epithelial origin.

PubMed Disclaimer

Similar articles

  • The role of TRPV6 in breast carcinogenesis.
    Bolanz KA, Hediger MA, Landowski CP. Bolanz KA, et al. Mol Cancer Ther. 2008 Feb;7(2):271-9. doi: 10.1158/1535-7163.MCT-07-0478. Epub 2008 Feb 1. Mol Cancer Ther. 2008. PMID: 18245667
  • TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
    Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N. Lehen'kyi V, et al. Oncogene. 2007 Nov 15;26(52):7380-5. doi: 10.1038/sj.onc.1210545. Epub 2007 May 28. Oncogene. 2007. PMID: 17533368
  • Optimization of TRPV6 Calcium Channel Inhibitors Using a 3D Ligand-Based Virtual Screening Method.
    Simonin C, Awale M, Brand M, van Deursen R, Schwartz J, Fine M, Kovacs G, Häfliger P, Gyimesi G, Sithampari A, Charles RP, Hediger MA, Reymond JL. Simonin C, et al. Angew Chem Int Ed Engl. 2015 Dec 1;54(49):14748-52. doi: 10.1002/anie.201507320. Epub 2015 Oct 12. Angew Chem Int Ed Engl. 2015. PMID: 26457814
  • Determining the Crystal Structure of TRPV6.
    Saotome K, Singh AK, Sobolevsky AI. Saotome K, et al. In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 14. In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 14. PMID: 30299652 Free Books & Documents. Review.
  • TRPV5 and TRPV6 Calcium-Selective Channels.
    Peng JB, Suzuki Y, Gyimesi G, Hediger MA. Peng JB, et al. In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 13. In: Kozak JA, Putney JW Jr, editors. Calcium Entry Channels in Non-Excitable Cells. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 13. PMID: 30299660 Free Books & Documents. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Biol Chem. 2004 Jul 16;279(29):30326-37 - PubMed
    1. Lab Invest. 2002 Dec;82(12):1755-64 - PubMed
    1. Clin Orthop Relat Res. 1995 Mar;(312):19-33 - PubMed
    1. Annu Rev Nutr. 1998;18:413-40 - PubMed
    1. J Biol Chem. 2008 Nov 14;283(46):31348-55 - PubMed

Publication types

MeSH terms